Pioneering Methods in Brain Optimization and Mental Health Treatment.
ACS medicinal chemistry letters – March 14, 2024
Source: PubMed
Summary
Breakthrough brain therapies combine AI-driven neurostimulation with carefully controlled psychedelic compounds to create personalized mental health treatments. Advanced algorithms analyze brain activity in real-time, allowing precise, non-invasive stimulation that works alongside natural compounds to optimize neural function. Early results show significant improvements in mood disorders and cognitive performance.
Abstract
This Patent Highlight explores ground-breaking advancements in neurostimulation, psychedelic therapy, and brain function optimization from recent innovations. It examines methods for altering brain states through AI-driven non-invasive neurostimulation, potentially contributing to personalized brain therapy. The publication also delves into the therapeutic potential of N-isopropyl tryptamines and tryptamine derivatives. Furthermore, it discusses the therapeutic applications of psilocybin and psilocin crystalline forms in mental health and central nervous system disorders. By comparing and contrasting these diverse approaches, this work highlights their mechanistic insights, therapeutic implications, and contributions to the evolving fields of neuroscience and mental health.